Aetna Inc. (AET) Shares Bought by Pictet & Cie Europe SA
Pictet & Cie Europe SA lifted its position in Aetna Inc. (NYSE:AET) by 7.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 16,097 shares of the company’s stock after acquiring an additional 1,150 shares during the quarter. Pictet & Cie Europe SA’s holdings in Aetna were worth $2,560,000 as of its most recent filing with the SEC.
Several other large investors have also recently modified their holdings of AET. Bruderman Asset Management LLC purchased a new stake in shares of Aetna in the 2nd quarter valued at approximately $106,000. Lloyds Banking Group plc purchased a new stake in shares of Aetna in the 3rd quarter valued at approximately $106,000. Moisand Fitzgerald Tamayo LLC purchased a new stake in shares of Aetna in the 3rd quarter valued at approximately $116,000. Liberty Capital Management Inc. lifted its position in shares of Aetna by 206.9% in the 2nd quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after acquiring an additional 629 shares in the last quarter. Finally, Westside Investment Management Inc. lifted its position in shares of Aetna by 53.5% in the 2nd quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock valued at $177,000 after acquiring an additional 400 shares in the last quarter. Institutional investors and hedge funds own 90.93% of the company’s stock.
In other news, EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares in the company, valued at approximately $5,465,734.55. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the sale, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.
Aetna Inc. (AET) traded up $3.76 during midday trading on Friday, reaching $174.76. 2,175,200 shares of the company’s stock traded hands, compared to its average volume of 2,437,205. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52. The firm has a market cap of $56,920.00, a price-to-earnings ratio of 16.75, a price-to-earnings-growth ratio of 1.56 and a beta of 0.61. Aetna Inc. has a 52 week low of $116.04 and a 52 week high of $184.98.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.06 by $0.39. The company had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business’s quarterly revenue was down 5.0% on a year-over-year basis. During the same period last year, the business posted $2.07 EPS. sell-side analysts forecast that Aetna Inc. will post 9.78 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were given a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, October 11th. This represents a $2.00 annualized dividend and a yield of 1.14%. Aetna’s dividend payout ratio is 36.97%.
AET has been the subject of several research analyst reports. Argus restated a “buy” rating and issued a $185.00 price target (up previously from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $174.00 target price for the company in a research report on Thursday, October 12th. Citigroup Inc. increased their target price on shares of Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a research report on Thursday, November 2nd. Jefferies Group LLC increased their target price on shares of Aetna from $163.00 to $165.00 and gave the stock a “hold” rating in a research report on Friday, October 13th. Finally, Deutsche Bank AG increased their target price on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. Eleven investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $172.36.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.